CAR-T
| CRISPR Medicine | This is an overview of articles on CAR-T
Sign-up to weekly Newsletter here.
IND Enabling
Phase I
Phase II
Phase III
Relapsed or refractory B-cell hematological malignancies, (NCT05381181)
Sponsors:
Bioray Laboratories
Sponsors:
Bioray Laboratories
IND Enabling
Phase I
Phase II
Phase III
IND Enabling
Phase I
Phase II
Phase III
Relapsed or Refractory Acute Lymphocytic Leukemia, ALL, (NCT06481735)
Sponsors:
Chinese PLA General Hospital
Sponsors:
Chinese PLA General Hospital
IND Enabling
Phase I
Phase II
Phase III
IND Enabling
Phase I
Phase II
Phase III
IND Enabling
Phase I
Phase II
Phase III
IND Enabling
Phase I
Phase II
Phase III
Relapsed or Refractory B-cell Lymphoma and Chronic Lymphocytic Leukemia, (NCT04245722)
Sponsors:
Fate Therapeutics
Sponsors:
Fate Therapeutics
IND Enabling
Phase I
Phase II
Phase III